Healthcare AI Leader Parminder Bhatia Joins Helio Genomics Board of Directors
Healthcare AI Leader Parminder Bhatia Joins Helio Genomics Board of Directors
Publish Date: 2026-07-16 08:16:00
Source Domain: www.prnewswire.com
IRVINE, Calif., July 16, 2026 /PRNewswire/ — Helio Genomics, Inc., a commercial-stage AI-powered precision liver diagnostics company focused on improving outcomes for at-risk patients through early cancer detection, disease surveillance, and biomarker-driven precision medicine, today announced the appointment of Parminder (Parry) Bhatia, Senior Vice President of Artificial Intelligence at Edwards Lifesciences, to its Board of Directors.
Parminder (Parry), Senior Vice President of Artificial Intelligence at Edwards Lifesciences, brings deep expertise in responsible AI deployment across regulated healthcare environments. Formerly the Chief AI Officer at GE HealthCare, he helped accelerate the company’s broader AI strategy across medical devices and software products in imaging and ultrasound, working across the organization to help advance AI-enabled product development and adoption. Parry also contributed to GE HealthCare’s enterprise Responsible AI efforts, in partnership with established governance and functional leaders. Prior to GE HealthCare, Parry held AI and machine learning science roles at Amazon, including work related to healthcare AI and generative AI initiatives. He has also held AI and machine learning roles at Microsoft and Georgia Tech.
A multiple award-winning innovator recognized by Modern Healthcare 40 Under 40, CDO Magazine, and Constellation Research, Parry holds a Bachelor of Science in Computer Science from the Indian Institute of Technology and a master’s degree in computational science and engineering with a focus on machine learning from the Georgia Institute of Technology.
“Parminder’s leadership in healthcare AI and responsible innovation will be invaluable as Helio scales its platform to detect cancer earlier and improve outcomes for patients worldwide,” said Dr. Bharat Tewarie, Chief Executive Officer of Helio Genomics. “His strategic perspective will strengthen our…
